As South Carolina's only National Cancer Institute (NCI)-designated cancer center – and one of only 66 NCI centers nationally – Hollings is a premier cancer research center in the southeastern US.

With more than $40 million in research funding, Hollings leads the way in groundbreaking research with the mission of improving care and treatments available to patients. We pride ourselves on our interdisciplinary collaborations within MUSC and with other nationally-recognized academic centers and the private biotech sector.

Through our commitment to cancer research, we seek to improve the preventive, diagnostic and therapeutic services to patients.